Brief: Core Laboratories Expects Q126 Revenue And Earnings Below Prior Guidance
23/03/2026 21:17
March 23 (Reuters) - Core Laboratories Inc CLB.N: CORE LABORATORIES OUTLOOK Q1 EPS USD 0.05-0.07 CORE LABORATORIES INC - PROJECTS Q1 2026 EPS, EX-ITEMS, OF $0.05-$0.07 CORE LABORATORIES INC - RESERVOIR DESCRIPTION SEGMENT MORE IMPACTED BY MIDDLE EAST CONFLICT CORE LABORATORIES INC - PRODUCTION ENHANCEMENT LESS AFFECTED; ENERGETICS SHIPMENTS DELAYED OR SUSPENDED CORE LABORATORIES INC: REVISED GUIDANCE FOR Q1 2026 REVENUE RANGES FROM $119 MILLION TO $123 MILLION CORE LABORATORIES INC - EXPECTS Q1 2026 REVENUE AND EARNINGS BELOW PRIOR GUIDANCE CORE LABORATORIES OUTLOOK Q1 ADJUSTED EPS USD 0.05-0.07 Source text: [ID:] Further company coverage: CLB.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Core Laboratories
See all newsCore Laboratories Q1 profit halves as Middle East disruptions, weather weigh
Brief: Core Laboratories Q1 EPS USD -0.02
Brief: Core Laboratories Expects Q126 Revenue And Earnings Below Prior Guidance
Brief: Core Laboratories Expects Q1 Rev Between $124 Mln To $130 Mln
Oilfield services firm Core Laboratories' Q4 revenue rises